Imaging Modality with Highest Accuracy in Diagnosing Myocardial Ischemia
Imaging modality that exhibits the highest accuracy for diagnosis of myocardial ischemia.
PET provides the highest accuracy for diagnosis of myocardial ischemia, according to an article published in JAMA Cardiology.
Researchers from the Netherlands, Finland, Canada, and the United States, performed a prospective clinical study to establish the diagnostic accuracy of coronary computed tomography angiography (CCTA), single-photon emission tomography (SPECT), and PET, and explore the incremental value of hybrid imaging compared with fractional flow reserve.
A total of 208 patients (132 men and 76 women, mean age of 58) participated in the study. All had suspected coronary artery disease (CAD) and had undergone CCTA, technetium 99m/tetrofosmin–labeled SPECT, and [15O]H2O PET with examination of all coronary arteries by fractional flow reserve. Two patients had incomplete or failed SPECT procedures caused by technical problems. Four patients failed to complete the cardiac PET protocol mainly because of claustrophobia or technical reasons. The scans were interpreted by core laboratories on an intention-to-diagnose basis. Hybrid images were generated in case of abnormal noninvasive anatomical or functional test results.
The results showed that 92 patients (44.2%) had significant CAD, with a fractional flow reserve of ≤0.80.
The researchers concluded that PET exhibited the highest accuracy for the diagnosis of myocardial ischemia, adding, “a combined anatomical and functional assessment does not add incremental diagnostic value but guides clinical decision-making in an unsalutary fashion.”
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
